by Clinical Neuropsychologist | Tuesday, December 10, 2024 | Neuroimaging
Abstract Background and Purpose The role of high-resolution nerve ultrasound (HRUS) in the diagnosis of chemotherapy-induced polyneuropathy is unclear. The present prospective longitudinal controlled study evaluates the utility of HRUS in vincristine-induced...
by Clinical Neuropsychologist | Monday, December 9, 2024 | Neuroimaging
Abstract Background and purpose Despite multimodal treatment of glioblastoma (GBM), recurrence beyond the initial tumor volume is inevitable. Moreover, conventional MRI has shortcomings that hinder the early detection of occult white matter tract infiltration by...
by Clinical Neuropsychologist | Sunday, December 1, 2024 | Neuroimaging
Abstract Background and Purpose Neuromix is a fast, motion robust multi-contrast sequence capable of providing all diagnostic contrasts in ∼3.5 minutes. However, more evaluation is needed across the various contrasts compared to gold standard, optimized sequences...
by Clinical Neuropsychologist | Friday, November 8, 2024 | Neuroimaging
Abstract Background and Purpose Neuromyelitis optica spectrum disorder (NMOSD) affects the optic nerves and spinal cord but can also cause focal brain inflammation. Subcortical pathology may contribute to the etiology of cognitive deficits in NMOSD. Using myelin water...
by Clinical Neuropsychologist | Wednesday, November 6, 2024 | Neuroimaging
Abstract Background and Purpose Different types of physical training can lead to changes in brain activity and function, and these changes can vary depending on the type of training. However, it remains unclear whether there are commonalities in how different types of...
by Clinical Neuropsychologist | Wednesday, November 6, 2024 | Neuroimaging
Abstract Background and Purpose The absence of a consensus data quality control (DQC) process inhibits the widespread adoption of MR spectroscopy. Poor DQC can lead to unreliable clinical diagnosis and irreproducible research conclusions. Currently, manual visual...
